# US Hemorrhoid Treatment Devices Market

> US Hemorrhoid Treatment Devices Market Research Report By Device Type (Non-surgical Devices, Surgical Devices, Minimally Invasive Devices), By Therapeutic Area (Internal Hemorrhoids, External Hemorrhoids, Thrombosed Hemorrhoids), By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings) and By Material (Silicone, Stainless Steel, Polymer) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.03%
- **2024:** $ 540.19 Million
- **2025:** $ 556.56 Million
- **2035:** $ 750.14 Million
- **Key Players:** Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Stryker Corporation (US), Conmed Corporation (US), Halyard Health (US), Smith & Nephew (GB)

**Report ID:** MRFR/HC/51549-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-hemorrhoid-treatment-devices-market-53310

---

## Market Summary

## **US Hemorrhoid Treatment Devices Market Overview**

As per MRFR analysis, the US Hemorrhoid Treatment Devices Market Size was estimated at 524.3 (USD Million) in 2023. The US Hemorrhoid Treatment Devices Market Industry is expected to grow from 550(USD Million) in 2024 to 780 (USD Million) by 2035. The US Hemorrhoid Treatment Devices Market CAGR (growth rate) is expected to be around 3.227% during the forecast period (2025 - 2035).

## **Key US Hemorrhoid Treatment Devices Market Trends Highlighted**

A growing awareness of health issues related to hemorrhoids and an aging population are driving significant trends in the US Hemorrhoid Treatment Devices Market. The demand for effective hemorrhoid treatment options in the United States is on the rise as the population ages. Consequently, manufacturers must innovate and offer solutions that are tailored to this demographic. Additionally, the transition to minimally invasive procedures is noteworthy, as patients favor treatment methods that minimize recovery time and relieve discomfort. Given the growing emphasis on patient-centered care within the United States healthcare system, this trend is especially pertinent.

Additionally, the proliferation of telehealth services has created the possibility of remote consultations, which have facilitated the provision of care to individuals with hemorrhoids. This broader access has the potential to improve patient outcomes by enabling earlier diagnosis and treatment. Furthermore, the market landscape is being transformed by the increasing prevalence of self-care and over-the-counter treatment options, as a greater number of patients are opting to self-manage their conditions before undergoing surgical interventions. 

Emerging technologies in hemorrhoid treatment devices are enabling the development of innovative products that improve safety and effectiveness. Patients are increasingly inclined to pursue treatment that aligns with their contemporary ways of life as a result of the development of non-invasive techniques and smart devices. In general, these trends underscore a dynamic market in the United States that is defined by a focus on patient preferences, technological advancements, and an increase in demand for hemorrhoid treatment.

Market players are presented with numerous opportunities to enhance the overall treatment experience by addressing patient requirements as a result of the ongoing development of effective treatment solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database, and Analyst Review

## **US Hemorrhoid Treatment Devices Market Drivers**

Increasing Incidence of Hemorrhoids Among the US Population

The growing prevalence of hemorrhoids significantly drives the US Hemorrhoid Treatment Devices Market. According to the American Society of Colon and Rectal Surgeons, approximately 75% of Americans experience hemorrhoids at some point in their lives, and the condition affects more than 10 million people annually. This high incidence rate necessitates the availability of effective treatment devices, fueling market growth as healthcare providers seek to offer advanced solutions. Companies like Medtronic and Ethicon Inc. are responding by developing innovative devices aimed at reducing patients' discomfort and enhancing recovery times, thereby increasing demand within the market.

Furthermore, the aging population in the US, with approximately 54 million individuals aged 65 and older expected by 2030, also contributes to a heightened need for hemorrhoid treatment, as the incidence of the condition typically escalates with age. Improved awareness initiatives and training programs by organizations such as the National Institute of Diabetes and Digestive and Kidney Diseases further promote early diagnosis and treatment, leading to increased market growth in the US Hemorrhoid Treatment Devices Market.

Advancements in Medical Technology

Technological advancements play a crucial role in driving the US Hemorrhoid Treatment Devices Market. Significant innovations, such as minimally invasive surgical techniques and advanced laser treatment devices, have enhanced treatment outcomes and reduced recovery times. The Healthcare Information and Management Systems Society emphasizes that minimally invasive procedures have increased in popularity due to their associated benefits, such as reduced pain and faster recovery, leading to more patients seeking these options. Companies like Cryoanalgesia and THD (Transanal Hemorrhoidal Dearterialization) are at the forefront of these advancements, developing cutting-edge devices that improve treatment efficacy.

The US Food and Drug Administration's ongoing approval of new devices and technologies further supports this trend, allowing for more treatment options that cater to diverse patient needs.

Growing Awareness and Acceptance of Treatment Options

The rising awareness of hemorrhoid treatment devices among patients and healthcare professionals in the United States is propelling the US Hemorrhoid Treatment Devices Market forward. Educational campaigns launched by organizations like the American Gastroenterological Association help inform the public and healthcare providers about the available devices and their benefits. This increased awareness is reflected in healthcare utilization; according to the Centers for Disease Control and Prevention, an estimated 1.4 million outpatient visits occur annually for hemorrhoid-related problems, demonstrating a growing acceptance of treatment options.

Furthermore, patients now prioritize quality of life and often explore non-invasive solutions, giving companies like ConMed and Medtronic increased opportunities to market their innovative treatment devices effectively, thus driving market growth.

## **US Hemorrhoid Treatment Devices Market Segment Insights**

### **Hemorrhoid Treatment Devices Market Device Type Insights**

The Device Type segment of the US Hemorrhoid Treatment Devices Market reflects a diversified approach to managing and treating hemorrhoids, encapsulating a range of devices that cater to different patient needs and treatment preferences. Non-surgical Devices typically hold a significant position within the market as they are often preferred by patients seeking less invasive treatment options. These devices include topical applications and rubber band ligators, which ensure patient comfort and convenience, driving their wider adoption in at-home treatments.

The surgical devices category represents a crucial portion of the market, as it encompasses various surgical interventions for hemorrhoid removal, encompassing procedures that are typically reserved for more severe cases. While they are less commonly sought out than non-surgical methods, advancements in surgical techniques and technology enhance patient recovery times and outcomes, making these devices a valued component of the Hemorrhoid Treatment Devices Market. Minimally Invasive Devices serve as a bridge between non-surgical and traditional surgical methods, offering solutions that yield effective results with significantly reduced recovery times and less discomfort for patients.

This segment is growing in importance as it strikes a balance between efficacy and patient-centered care, emphasizing the need for options that minimize patient discomfort while effectively addressing the condition. Collectively, these device types contribute to the comprehensive landscape of the US Hemorrhoid Treatment Devices Market, highlighting the demand for different treatment modalities as well as the trends toward less invasive and more effective approaches to care. By offering a spectrum of choices, healthcare providers can better meet the varied needs of patients while enhancing overall treatment satisfaction and outcomes.

The increasing incidence of hemorrhoids, propelled by lifestyle factors and an aging population, provides ample opportunity for growth across all device types. As the market evolves, manufacturers and healthcare providers need to remain attuned to patient preferences and advancements in technology that could improve treatment efficacy and safety in this specialized sector.

Source: Primary Research, Secondary Research, _Market Research Future_ Database, and Analyst Review

### **Hemorrhoid Treatment Devices Market Therapeutic Area Insights**

The US Hemorrhoid Treatment Devices Market focuses significantly on the Therapeutic Area, which encompasses a variety of conditions impacting individuals. Among these, Internal Hemorrhoids often dominate, primarily due to their prevalence and the discomfort they cause, leading to increased demand for effective treatment devices. External Hemorrhoids also hold a considerable share of the market as they tend to be more visible and, consequently, more concerning to patients. The significance of Thrombosed Hemorrhoids cannot be overlooked, as they are often associated with acute pain and severe symptoms, promoting the need for specialized treatment devices.

This diverse segmentation enables targeted solutions tailored to individual patient needs. With the growing awareness of treatment options and improved patient education, the market is anticipated to see progress in innovative devices and techniques. Such advancements are essential to cater to the varied needs stemming from the different types of hemorrhoidal conditions present in the US population. Companies operating in this market are challenged to stay abreast of evolving patient needs while navigating competitive pressures and regulatory standards, which can significantly impact market growth.

The segmentation not only reinforces the necessity for ongoing Research and Development efforts but also highlights substantial opportunities for market players to develop novel treatment approaches aimed at improving patient experiences and outcomes.

### **Hemorrhoid Treatment Devices Market End User Insights**

The US Hemorrhoid Treatment Devices Market exhibits a diverse segmentation, particularly in the End User category, which plays a crucial role in the overall market dynamics. Hospitals represent a significant portion of the end-user segment, offering specialized care and advanced technology for hemorrhoid treatments, thus attracting a large number of patients seeking effective surgical interventions. Ambulatory Surgical Centers are also gaining traction due to their cost-effectiveness and the convenience they provide for outpatient procedures, making them an appealing option for both patients and healthcare providers.

Homecare settings are increasingly relevant as they provide a more comfortable, personalized healing environment, allowing patients to manage their recovery from home. This shift towards home care is driven by the growing demand for less invasive treatments and the ease of access to care, reflecting broader healthcare trends in the US, where patients prioritize convenience and comfort. Each of these settings caters to different healthcare needs, underlining the importance of tailored treatment options within the US Hemorrhoid Treatment Devices Market.

### **Hemorrhoid Treatment Devices Market Material Insights**

The Material segment of the US Hemorrhoid Treatment Devices Market encompasses various critical components that cater to the growing healthcare needs associated with hemorrhoid treatments. With an increasing prevalence of hemorrhoidal conditions, driven by factors such as dietary habits and sedentary lifestyles, there is a rising demand for effective treatment devices. Among the materials, Silicone is valued for its flexibility and biocompatibility, making it a popular choice for consumer-friendly products. Stainless Steel stands out for its durability and ease of sterilization, appealing to healthcare professionals and institutions focused on infection control.

Polymer materials provide lightweight, cost-effective solutions with diverse applications in medical devices, contributing significantly to innovation in the market. The diversity of these materials fosters market growth by meeting the specific needs of patients and healthcare providers, enhancing treatment effectiveness, and ensuring patient safety. As these materials evolve, they offer opportunities for advancements in design and functionality, paving the way for new solutions in the management of hemorrhoidal issues in the US.

**US Hemorrhoid Treatment Devices Market Key Players and Competitive Insights:**

The US Hemorrhoid Treatment Devices Market is a significant segment within the broader healthcare industry, focused on providing solutions for the management and treatment of hemorrhoids, a common condition affecting a large percentage of the population. This market encompasses a variety of devices and products designed to alleviate symptoms, reduce complications, and improve patient quality of life. Key players in this market utilize innovative technologies and advanced treatment protocols to differentiate their offerings, thus fostering a highly competitive environment. 

Additionally, regulatory dynamics and evolving patient preferences further shape the competitive landscape, prompting companies to invest in research and development to enhance product efficacy and safety. ConMed is a prominent player in the US Hemorrhoid Treatment Devices Market, recognized for its commitment to innovation and quality. The company's extensive portfolio includes advanced surgical instruments that are designed to support surgical procedures related to hemorrhoid treatment, which holds a significant position within the industry. ConMed focuses on delivering high-quality, effective solutions that cater to various patient needs, thereby strengthening its market presence. 

Their robust distribution network and well-established relationships within the medical community allow for widespread access to their products, enhancing brand recognition and reliability among healthcare providers. This ability to meet healthcare professionals' demands, combined with an emphasis on technological advancements, positions ConMed as a strong competitor in this market segment. Cook Medical plays a crucial role in the US Hemorrhoid Treatment Devices Market, known for its diverse product offerings that include minimally invasive devices and innovative treatments for hemorrhoids.

The company has developed several key products that are specifically designed to address the unique challenges associated with hemorrhoid treatment, focusing on improving procedural outcomes and patient recovery times. Cook Medical's strong market presence is bolstered by its commitment to research and development, which has led to the introduction of new technologies and therapeutic approaches. 

The company's strategic initiatives include mergers and acquisitions that enhance its capabilities and market share within the US, allowing it to expand its product line and fortify its position in the competitive landscape. Cook Medical's dedication to meeting the evolving needs of patients and healthcare professionals ensures it remains a formidable competitor in the hemorrhoid treatment devices market.

**Key Companies in the US Hemorrhoid Treatment Devices Market Include:**

**US Hemorrhoid Treatment Devices Market Industry Developments**

Recent developments in the US Hemorrhoid Treatment Devices Market have indicated a growth trajectory due to the increasing prevalence of hemorrhoids and advancements in treatment technologies. In August 2023, Boston Scientific launched a new line of biodegradable bandages for hemorrhoid treatment, which may enhance post-operative recovery. Simultaneously, Johnson and Johnson and Medtronic reported significant increases in their market valuations, reflecting growing demand for minimally invasive treatment options. In September 2022, Cook Medical expanded its product range with a new hemorrhoidal band ligator, enhancing its foothold in the market. 

Notably, in March 2023, Smith and Nephew acquired a small innovative firm focused on digital health solutions for post-operative care, indicating a strategic move towards integrated healthcare technologies. Mergers and acquisitions have also been a significant theme, as Stryker acquired a company specializing in medical devices related to gastrointestinal health in July 2023, strengthening its position within the sector. Over the last few years, increased investment in Research and Development has allowed companies like ConMed and 3M to introduce novel treatment alternatives, further boosting market growth and competition.

## **Hemorrhoid Treatment Devices Market Segmentation Insights**

### **Hemorrhoid Treatment Devices Market Device Type Outlook**

### **Hemorrhoid Treatment Devices Market Therapeutic Area Outlook**

### **Hemorrhoid Treatment Devices Market End User Outlook**

### **Hemorrhoid Treatment Devices Market Material Outlook**

## Market Drivers

### Rising Healthcare Expenditure

The upward trend in healthcare spending in the United States is another driver for the hemorrhoid treatment-devices market. As individuals allocate more resources towards health and wellness, there is a corresponding increase in the demand for effective treatment options. The U.S. healthcare expenditure is projected to reach $4 trillion by 2026, with a significant portion directed towards outpatient treatments, including those for hemorrhoids. This financial commitment indicates a willingness among consumers to invest in advanced treatment devices, thereby fostering growth in the hemorrhoid treatment-devices market. The market is likely to see a surge in new product introductions as companies respond to this increased spending.

### Growing Awareness and Education

Increased awareness regarding hemorrhoid conditions and available treatment options is significantly influencing the hemorrhoid treatment-devices market. Educational campaigns by healthcare organizations and online platforms have empowered patients to seek timely treatment. This heightened awareness is likely to lead to earlier diagnoses and increased utilization of treatment devices. As patients become more informed about their options, the demand for effective hemorrhoid treatment devices is expected to rise. Market analysts suggest that this trend could contribute to a growth rate of approximately 4% in the coming years, as more individuals actively pursue solutions for their symptoms.

### Advancements in Medical Technology

Technological innovations play a crucial role in shaping the hemorrhoid treatment-devices market. The introduction of minimally invasive devices, such as rubber band ligators and infrared coagulation units, has transformed treatment approaches. These advancements not only enhance patient comfort but also improve recovery times, making them more appealing to both patients and healthcare providers. The market for these devices is projected to reach approximately $1 billion by 2026, reflecting a compound annual growth rate (CAGR) of around 6%. As technology continues to evolve, the hemorrhoid treatment-devices market is expected to benefit from new product developments that offer greater efficacy and safety.

### Shift Towards Home-Based Treatments

The trend towards home-based healthcare solutions is reshaping the hemorrhoid treatment-devices market. Patients increasingly prefer to manage their conditions at home, leading to a rise in demand for over-the-counter treatment devices. This shift is driven by the convenience and privacy associated with home treatments, as well as the desire to avoid hospital visits. Market data suggests that the home-use segment of the hemorrhoid treatment-devices market could grow by approximately 7% annually. As manufacturers develop user-friendly devices for home use, this segment is expected to expand, reflecting changing consumer preferences and the ongoing evolution of healthcare delivery.

### Increasing Prevalence of Hemorrhoids

The rising incidence of hemorrhoids in the population is a primary driver for the hemorrhoid treatment-devices market. Factors such as sedentary lifestyles, poor dietary habits, and an aging population contribute to this trend. According to recent health statistics, approximately 50% of adults will experience hemorrhoids by the age of 50. This growing prevalence necessitates effective treatment options, thereby boosting demand for various hemorrhoid treatment devices. As more individuals seek relief from symptoms, the market is likely to expand, with an estimated growth rate of around 5% annually. This trend indicates a robust opportunity for manufacturers and healthcare providers to innovate and offer advanced treatment solutions in the hemorrhoid treatment-devices market.

## Future Outlook

The [Hemorrhoid Treatment Devices Market](https://www.marketresearchfuture.com/reports/hemorrhoid-treatment-devices-market-8726) is projected to grow at 3.03% CAGR from 2025 to 2035, driven by increasing awareness and technological advancements.

**New opportunities:**

- Development of portable, user-friendly treatment devices for home use. Expansion into telehealth services for remote consultations and follow-ups. Partnerships with healthcare providers for integrated treatment solutions.

By 2035, the market is expected to achieve robust growth, reflecting evolving consumer needs and innovative solutions.

## Segment Insights

### By Device Type: Non-surgical Devices (Largest) vs. Minimally Invasive Devices (Fastest-Growing)

In the US hemorrhoid treatment-devices market, the distribution of market share among device types reveals a clear preference for non-surgical devices, solidifying their position as the largest segment. Non-surgical options dominate due to their accessibility and perceived safety among patients, making up a significant portion of the market. On the other hand, minimally invasive devices represent a rapidly growing segment, appealing to those seeking effective solutions with minimal recovery time.

Growth trends in this segment are driven by an increasing awareness of alternative treatment options and advancements in technology, which enhance device effectiveness and patient experience. The demand for less invasive procedures continues to rise, with healthcare providers and patients alike showing preference for solutions that may lead to less discomfort and quicker recovery. This trend is expected to persist, positioning minimally invasive devices for notable growth in the coming years.

Non-surgical Devices: Dominant vs. Minimally Invasive Devices: Emerging

Non-surgical devices are recognized as the dominant force in the market, primarily due to their extensive utilization and patient-friendly nature. These devices typically include topical treatments, oral medications, and other over-the-counter options that provide effective management of hemorrhoids with minimal side effects. On the other hand, minimally invasive devices have emerged as a compelling alternative, offering advantages such as shorter procedure times and reduced recovery durations. This segment is increasingly appealing to patients seeking quick relief with minimal disruption to their daily lives. As innovation continues in device design and efficacy, minimally invasive options are projected to gain greater traction, thereby complementing the steady demand for non-surgical solutions.

### By Therapeutic Area: Internal Hemorrhoids (Largest) vs. External Hemorrhoids (Fastest-Growing)

In the US hemorrhoid treatment-devices market, Internal Hemorrhoids currently represent the largest segment, capturing a significant market share due to their prevalence and the increasing demand for effective treatment options. External Hemorrhoids are gaining traction as well, driven by rising awareness and preference for non-invasive procedures. Thrombosed Hemorrhoids, while relevant, exhibit a comparatively smaller share in the market landscape as they cater to a more specific group of patients.

The growth trends for these segments indicate a shifting landscape in treatment preferences, with patients and healthcare providers favoring innovative technological solutions. The increasing incidence of hemorrhoids, coupled with advancements in minimally invasive device technologies, accelerates market expansion. Furthermore, robust marketing strategies and improved accessibility to treatment options are empowering patients to seek timely intervention, thereby propelling the overall growth of certain segments within this market.

Internal Hemorrhoids (Dominant) vs. External Hemorrhoids (Emerging)

Internal Hemorrhoids are the dominant segment, primarily due to their high prevalence and effective intervention options available on the market. These devices focus on alleviating discomfort associated with internal hemorrhoids, making them a preferred choice for many patients. On the other hand, External Hemorrhoids, while emerging, are becoming increasingly popular owing to their associated treatments that are less invasive and often preferred for outpatient procedures. The evidence suggests that patients undergoing treatment for External Hemorrhoids are driven by convenience and effectiveness, providing opportunities for market players to innovate and expand their offerings specifically catered to those suffering from this condition.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the US hemorrhoid treatment-devices market, hospitals hold the largest market share, driven by their advanced infrastructure and comprehensive healthcare services that facilitate effective treatment of various hemorrhoid conditions. In contrast, ambulatory surgical centers represent the fastest-growing segment, benefitting from the shift towards outpatient care models and an increasing preference for minimally invasive procedures.

Growth trends in this segment are influenced by several factors including the rising incidence of hemorrhoids, an aging population, and advancements in treatment technologies. Additionally, homecare settings are gaining traction as patients seek comfort and convenience in receiving treatment at home. The growing awareness of available treatments and the shift in patient preferences will further accelerate the growth of these segments.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals dominate the US hemorrhoid treatment-devices market due to their capacity to provide a range of services, including surgical interventions and post-operative care. They have access to advanced technologies and skilled healthcare professionals, ensuring comprehensive treatment plans for patients. On the other hand, ambulatory surgical centers are emerging as a strong alternative, offering efficient, cost-effective, and patient-friendly options for treatment. Their growth is propelled by the demand for outpatient procedures and the increasing focus on reducing healthcare costs while maintaining quality care. The distinction between these segments highlights a shift towards more accessible treatment options without compromising patient outcomes.

### By Material: Silicone (Largest) vs. Stainless Steel (Fastest-Growing)

In the US hemorrhoid treatment-devices market, the material segment is witnessing a notable distribution of shares among Silicone, Stainless Steel, and Polymer. Silicone currently leads the market due to its superior properties such as flexibility and comfort, making it the preferred choice for patients. Stainless Steel, while having a smaller share, is experiencing rapid growth thanks to its durability and effectiveness. Polymer, on the other hand, is positioned as an emerging option, appealing to a niche market due to its lightweight and cost-effectiveness.

Growth trends in this segment are being driven by increased consumer awareness and advancements in material technology. The demand for Silicone products is bolstered by their biocompatibility and ease of use, establishing them as the dominant choice. Meanwhile, the Stainless Steel segment is gaining traction as manufacturers innovate to enhance product features, positioning it as the fastest-growing material. As healthcare providers seek more reliable solutions, Polymer's unique characteristics are also capturing attention, setting a foundation for its future market presence.

Silicone (Dominant) vs. Stainless Steel (Emerging)

Silicone stands out as the dominant material in the US hemorrhoid treatment-devices market, primarily due to its favorable properties such as flexibility, comfort, and ease of sterilization. This material has been accepted widely in various medical applications, leading to a strong consumer preference. In contrast, Stainless Steel is emerging as a competitive alternative, driven by its robustness and effectiveness in treatment. The market is witnessing innovations that improve the usability of Stainless Steel devices, making them suitable for patients seeking more durable options. While Silicone continues to lead, the emergence of Stainless Steel indicates a growing interest in diverse materials, offering consumers a broader range of treatment options tailored to their specific needs.

## Competitive Benchmarking

The hemorrhoid treatment-devices market is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Medtronic (US), Boston Scientific (US), and Johnson & Johnson (US) are actively pursuing growth through technological advancements and market expansion. Medtronic (US) focuses on enhancing its product portfolio with minimally invasive solutions, while Boston Scientific (US) emphasizes the integration of digital health technologies to improve patient outcomes. Johnson & Johnson (US) appears to be leveraging its extensive distribution network to penetrate emerging markets, thereby enhancing its competitive positioning. Collectively, these strategies contribute to a dynamic environment where innovation and operational efficiency are paramount.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain resilience. The market structure is moderately fragmented, with several players vying for market share. This fragmentation allows for a diverse range of products and services, but it also intensifies competition among key players. The influence of major companies is significant, as they set industry standards and drive technological advancements that smaller firms must adapt to in order to remain competitive.
In October Medtronic (US) announced the launch of a new line of hemorrhoid treatment devices that utilize advanced imaging technology to enhance procedural accuracy. This strategic move is likely to position Medtronic (US) as a leader in the market, as it addresses the growing demand for precision in medical procedures. The introduction of such innovative products may not only improve patient outcomes but also strengthen Medtronic's (US) market share in a competitive landscape.
In September Boston Scientific (US) entered into a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its hemorrhoid treatment devices. This collaboration is indicative of a broader trend towards digital health solutions, which are becoming increasingly important in patient management. By enhancing its product offerings with telehealth features, Boston Scientific (US) is likely to improve patient engagement and satisfaction, thereby solidifying its competitive edge.
In August Johnson & Johnson (US) completed the acquisition of a smaller firm specializing in biodegradable hemorrhoid treatment devices. This acquisition not only expands Johnson & Johnson's (US) product portfolio but also aligns with the growing consumer preference for sustainable medical solutions. The strategic importance of this move lies in its potential to attract environmentally conscious consumers, thereby differentiating Johnson & Johnson (US) in a crowded market.
As of November the competitive trends in the hemorrhoid treatment-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are playing a crucial role in shaping the landscape, as companies seek to leverage complementary strengths to enhance their offerings. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift underscores the importance of adaptability and forward-thinking strategies in maintaining a competitive advantage.

## Recent News & Developments

Recent developments in the US Hemorrhoid Treatment Devices Market have indicated a growth trajectory due to the increasing prevalence of hemorrhoids and advancements in treatment technologies. In August 2023, Boston Scientific launched a new line of biodegradable bandages for hemorrhoid treatment, which may enhance post-operative recovery. Simultaneously, Johnson and Johnson and Medtronic reported significant increases in their market valuations, reflecting growing demand for minimally invasive treatment options. In September 2022, Cook Medical expanded its product range with a new hemorrhoidal band ligator, enhancing its foothold in the market. 

Notably, in March 2023, Smith and Nephew acquired a small innovative firm focused on digital health solutions for post-operative care, indicating a strategic move towards integrated healthcare technologies. Mergers and acquisitions have also been a significant theme, as Stryker acquired a company specializing in medical devices related to gastrointestinal health in July 2023, strengthening its position within the sector. Over the last few years, increased investment in Research and Development has allowed companies like ConMed and 3M to introduce novel treatment alternatives, further boosting market growth and competition.

## Report Scope

| MARKET SIZE 2024 | 540.19(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 556.56(USD Million) |
| MARKET SIZE 2035 | 750.14(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.03% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Stryker Corporation (US), Conmed Corporation (US), Halyard Health (US), Smith & Nephew (GB) |
| Segments Covered | Device Type, Therapeutic Area, End User, Material |
| Key Market Opportunities | Integration of advanced minimally invasive technologies enhances patient comfort and treatment efficacy in the hemorrhoid treatment-devices market. |
| Key Market Dynamics | Rising consumer awareness drives demand for innovative hemorrhoid treatment-devices amid evolving regulatory standards. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US hemorrhoid treatment-devices market?**
A: The market valuation was $540.19 Million in 2024.

**Q: What is the projected market size for the US hemorrhoid treatment-devices market by 2035?**
A: The market is expected to reach $750.14 Million by 2035.

**Q: What is the expected CAGR for the US hemorrhoid treatment-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR is 3.03% during the forecast period.

**Q: Which companies are the key players in the US hemorrhoid treatment-devices market?**
A: Key players include Medtronic, Boston Scientific, Johnson & Johnson, B. Braun Melsungen AG, Stryker Corporation, Conmed Corporation, Halyard Health, and Smith & Nephew.

**Q: What are the main segments of the US hemorrhoid treatment-devices market?**
A: The main segments include Device Type, Therapeutic Area, End User, and Material.

**Q: How did the Non-surgical Devices segment perform in 2024?**
A: The Non-surgical Devices segment was valued at $200.0 Million in 2024 and is projected to grow to $270.0 Million.

**Q: What is the valuation of Surgical Devices in the US hemorrhoid treatment-devices market?**
A: The Surgical Devices segment was valued at $150.0 Million in 2024, with a projected increase to $200.0 Million.

**Q: What is the market size for Internal Hemorrhoids treatment devices?**
A: The Internal Hemorrhoids segment was valued at $200.0 Million in 2024 and is expected to grow to $300.0 Million.

**Q: Which material segment shows the highest valuation in the US hemorrhoid treatment-devices market?**
A: The Polymer material segment was valued at $270.99 Million in 2024, with a projected increase to $375.14 Million.

**Q: What is the expected growth for Homecare Settings as an end user in the market?**
A: The Homecare Settings segment was valued at $190.19 Million in 2024 and is projected to grow to $260.14 Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-hemorrhoid-treatment-devices-market-53310*